Access a curated library of reports, policy submissions, data insights, and other materials informing Canada’s life sciences ecosystem.
IMC appears before the CIIT to support its study of Canada’s trade agreements and trade and investment policies regarding how they may help or hinder the production and distribution of COVID-19 vaccines domestically and abroad.
IMC encourages the federal government to commit to building Canada’s domestic life sciences sector and manufacturing capacity. This follows IMC’s proposal in fall 2020 to establish a public-private biomanufacturing accelerator.
Stay informed with timely, relevant content on key issues shaping our industry.
